This ASX All Ordinaries share shrugged off the red to reach a new 52-week high today

We take a look at an All Ordinaries share that outperformed the index, and itself, today.

| More on:
Four people on the beach leap high into the air.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX All Ordinaries healthcare share Ebos outperformed the index today 
  • The company's share price is trading at an all-time high 
  • The All Ordinaries Index slipped 0.89% in today's trade 

The All Ordinaries Index (ASX: XAO) fell 0.89% today. But this share bucked the trend to leap higher.

The Ebos Group Ltd (ASX: EBO) share price climbed 1.76% today to close at a yearly high $41.57.

Let's take a look at the Ebos Group in more detail.

What does this ASX All Ordinaries share do?

Ebos is a marketer, wholesaler and distributor of healthcare, medical, animal care and pharmaceutical products in Australia, New Zealand and South East Asia.

Healthcare represents 87% of the company's business, with the other 13% of the company devoted to animal care.

Ebos shares are currently trading at an all-time high.

In a recent investor presentation, Ebos highlighted it makes over 12 million deliveries a year to healthcare providers and end markets.

Ebos reported $10.7 billion in revenue in the 2022 financial year. While underlying net profit after tax (NPAT) lifted 21.3% to $228.2 million.

The company delivered a final dividend of NZ 49 cents per share in FY22. Overall in FY22, Ebos delivered 96 cents per share of dividends to investors, up 8.5% on the previous year.

Ebos has acquired 20 companies since 2014. In May, Ebos acquired LifeHealthcare, one of the largest medical device distributors in Australia, New Zealand and South East Asia. Ebos sees this acquisition as an expansion opportunity. Commenting on this acquisition in November, Ebos said: "The LifeHealthcare acquisition established our presence in Southeast Asia and opens other potential opportunities in the region."

Ebos share price snapshot

The Ebos share price has climbed 4.45% in the last year. Meanwhile, Ebos shares are up 8.54% year to date. The All Ords share has a market capitalisation of $7.78 billion.

For perspective, the ASX All Ordinaries Index has shed 8.2% in the past year and 7.48% in the year to date.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »